Voyager Therapeutics - Stock Price History | VYGR

Historical daily share price chart and data for Voyager Therapeutics since 2019 adjusted for splits. The latest closing stock price for Voyager Therapeutics as of December 10, 2019 is 13.95.
  • The all-time high Voyager Therapeutics stock closing price was 31.31 on March 06, 2018.
  • The Voyager Therapeutics 52-week high stock price is 28.79, which is 106.4% above the current share price.
  • The Voyager Therapeutics 52-week low stock price is 7.76, which is 44.4% below the current share price.
  • The average Voyager Therapeutics stock price for the last 52 weeks is 17.69.
Voyager Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 18.3287 17.6300 31.3100 8.5900 9.4000 -43.37%
2017 12.6593 11.9700 25.8800 8.2400 16.6000 30.30%
2016 12.5015 21.1500 21.1500 8.5600 12.7400 -41.83%
2015 23.0354 17.7500 30.2000 17.5000 21.9000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.518B $0.008B
Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington's disease as well as VY-SMN101 for neuromuscular disease. Voyager Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $61.181B 11.15
Teva Pharmaceutical Industries (TEVA) Israel $10.834B 4.41
Bausch Health Cos (BHC) Canada $10.259B 6.77
Mylan (MYL) United States $9.956B 4.47
Dr Reddy's Laboratories (RDY) India $6.698B 17.57
ASPEN PHARMACR (APNHY) South Africa $3.391B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.198B 11.59
Amphastar Pharmaceuticals (AMPH) United States $0.888B 46.15
Homology Medicines (FIXX) United States $0.800B 0.00
Akorn (AKRX) United States $0.473B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.442B 0.00
Assembly Biosciences (ASMB) United States $0.428B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.287B 0.39
Adamas Pharmaceuticals (ADMS) United States $0.180B 0.00
Sol-Gel Technologies (SLGL) Israel $0.158B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.131B 0.00
CymaBay Therapeutics (CBAY) United States $0.120B 0.00
Teligent (TLGT) United States $0.033B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00